Search
for
Sort by
Research 30 of 117
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Dupilumab for alopecia areata treatment: A double‐edged sword?
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Alopecia Areata: A Complex Cytokine Driven Disease
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- New drugs under investigation for the treatment of alopecias
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- 1406 DETECTION OF MEMBRANE ANDROGEN-BINDING SITE IN LIVING RAT PROSTATE AND EVALUATION OF ITS ROLE IN PROSTATE BLOOD FLOW REGULATION
- Small Molecule Agents Against Alopecia: Potential Targets and Related Pathways
- Hydroxytyrosol Alleviates Acute Liver Injury by Inhibiting the TNF-α/PI3K/AKT Signaling Pathway via Targeting TNF-α Signaling
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Immune therapies for alopecia areata: evidence and new perspectives
- New Modalities in the Treatment of Refractory Alopecia Areata
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- New Drugs for Alopecias
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Treating Alopecia Areata: Current Practices Versus New Directions
- Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation